LCII vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
LCII exhibits strong fundamental health with a Piotroski F-Score of 7/9 and trades significantly below its growth-based intrinsic value of $223.31. While the Graham Number suggests a more conservative defensive value of $97.87, the company's explosive earnings growth (104.2% YoY) and low Price/Sales ratio (0.70) indicate substantial undervaluation. Despite bearish insider sentiment and a current technical downturn, the company's profitability and liquidity metrics far outperform its sector peers.
Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.
Compare Another Pair
Related Comparisons
LCII vs TSLA: Head-to-Head Comparison
This page compares LCI Industries (LCII) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.